We have located links that may give you full text access.
Mohs micrographic surgery for eyelid sebaceous carcinoma: a multicenter cohort of 360 patients.
Journal of the American Academy of Dermatology 2019 January 10
BACKGROUND: The decision to perform Mohs micrographic surgery (MMS) or wide local excision (WLE) for eyelid sebaceous carcinoma (SC) is controversial.
OBJECTIVE: To compare local recurrence, metastasis, and tumor-related mortality of patients with eyelid SC who were initially treated with MMS versus WLE.
METHODS: A multicenter cohort study. Medical records were reviewed for factors associated with recurrence, metastasis and tumor-related mortality. All eligible patients were followed up. The impact of initial surgical modality on the prognoses were determined by Cox analyses after controlling all confounders.
RESULTS: Among 360 patients included in this cohort, 115 (31.9%) of them underwent MMS as primary resection, whereas 245 (68.1%) cases underwent WLE. After a median follow-up period of 60.0 months, local recurrence was observed in 18 (15.7%) patients of the MMS group and 97 (39.6%) patients of the WLE group. Metastasis occurred in 9 (7.8%) patients who underwent MMS and 38 (15.5%) who underwent WLE. Six (5.2%) patients in the MMS group and 21 (8.6%) in the WLE group died of metastatic SC. Multivariable Cox regression indicated that, compared with the WLE group, the MMS group exhibited more favorable local recurrence control (HR=0.42; 95%CI:0.24-0.73; p=0.002), but a comparable metastasis rate (HR=1.38; 95%CI:0.60-3.18; p=0.453) and tumor-related mortality (HR=1.70; 95%CI:0.59-4.93; p=0.329). However, this beneficial effect became nonremarkable for patients with pagetoid intraepithelial neoplasia (HR=1.73; 95%CI:0.37-8.21; p=0.488).
LIMITATIONS: Retrospective nature.
CONCLUSION: MMS should be proposed for eyelid SC without orbital involvement to achieve recurrence control, however, this surgery did not change the long-term outcomes in terms of metastasis and tumor-related mortality. Patients with pagetoid intraepithelial neoplasia may require adjuvant measures.
OBJECTIVE: To compare local recurrence, metastasis, and tumor-related mortality of patients with eyelid SC who were initially treated with MMS versus WLE.
METHODS: A multicenter cohort study. Medical records were reviewed for factors associated with recurrence, metastasis and tumor-related mortality. All eligible patients were followed up. The impact of initial surgical modality on the prognoses were determined by Cox analyses after controlling all confounders.
RESULTS: Among 360 patients included in this cohort, 115 (31.9%) of them underwent MMS as primary resection, whereas 245 (68.1%) cases underwent WLE. After a median follow-up period of 60.0 months, local recurrence was observed in 18 (15.7%) patients of the MMS group and 97 (39.6%) patients of the WLE group. Metastasis occurred in 9 (7.8%) patients who underwent MMS and 38 (15.5%) who underwent WLE. Six (5.2%) patients in the MMS group and 21 (8.6%) in the WLE group died of metastatic SC. Multivariable Cox regression indicated that, compared with the WLE group, the MMS group exhibited more favorable local recurrence control (HR=0.42; 95%CI:0.24-0.73; p=0.002), but a comparable metastasis rate (HR=1.38; 95%CI:0.60-3.18; p=0.453) and tumor-related mortality (HR=1.70; 95%CI:0.59-4.93; p=0.329). However, this beneficial effect became nonremarkable for patients with pagetoid intraepithelial neoplasia (HR=1.73; 95%CI:0.37-8.21; p=0.488).
LIMITATIONS: Retrospective nature.
CONCLUSION: MMS should be proposed for eyelid SC without orbital involvement to achieve recurrence control, however, this surgery did not change the long-term outcomes in terms of metastasis and tumor-related mortality. Patients with pagetoid intraepithelial neoplasia may require adjuvant measures.
Full text links
Related Resources
Get seemless 1-tap access through your institution/university
For the best experience, use the Read mobile app
All material on this website is protected by copyright, Copyright © 1994-2024 by WebMD LLC.
This website also contains material copyrighted by 3rd parties.
By using this service, you agree to our terms of use and privacy policy.
Your Privacy Choices
You can now claim free CME credits for this literature searchClaim now
Get seemless 1-tap access through your institution/university
For the best experience, use the Read mobile app